Sickle Cell Disease Comprehensive Management for Primary Care Providers
This conference is designed to provide primary care providers such as internists, general practitioners, emergency room physicians, hospitalists, advanced care practice nurses, registered nurses, and social workers with the information they need to treat sickle cell disease pediatric and adult patients. There is no charge for this conference and continuing medical and nursing hours will be provided.
Target Audience
The target audience for this conference is primary care providers, such as internists, general practitioners, emergency room physicians, hospitalists, advanced care practice nurses, registered nurses, and social workers.
Learning Objectives
To familiarize primary care providers (PCPs) with the pathophysiological processes, diagnostic evaluation, and medical management of sickle hemoglobinopathies and their complications.
Current standards of care, clinical research advances, and new treatment options will also be addressed to assist PCPs in the management of SCD. Healthcare providers are in an era of increased routine screening, assessment, and management of chronic complications not previously seen in the care of persons with SCD, and more persons living with SCD are relying on PCPs in non-specialty practices for comprehensive disease management.
Attendees will gain awareness of current guidelines for management of sickle cell
pain as evidenced by knowledge assessment and by participation in case studies
portraying patients presenting with pain.
|
| |
9:00am - 9:15am | Welcome |
Steve Goodman, PhD, Moderator
|
9:15am - 9:45am | Sickle Cell Disease Overview | Wally Smith, MD |
9:45am - 10:30am | Caring for the Child from Birth to Transition | Jane Hankins, MD, MS |
10:30am - 11:00am | Managing Acute and Chronic Pain | Wally Smith, MD |
11:00am – 11:15am | Break |
|
11:15am – 12:00pm | Hydroxyurea Therapy for Sickle Cell Disease | Russell Ware, MD, PhD |
12:00pm - 1:00pm |
Conference Lunch Provided
|
|
1:00pm - 1:30pm | Stroke Prevention and Treatment | Russell Ware, MD, PhD |
1:30pm - 2:30pm | Living with Sickle Cell Disease | Jackie Sharp, DNP, APRN, PMHMP-BC Bria Sharp, UTHSC, College of Nursing Student |
2:30pm - 3:00pm |
Implementing Evidence Based Care for Vasso Occlusive Events in the ED
| Paula J. Tanabe, PhD, MSN, FAAN |
3:00pm – 3:15pm | Break |
|
3:15pm - 3:45pm | Acute Chest Syndrome and Pulmonary Complications | Artangela Henry, DNP, AGACNP-BC, FNP-C, CLSSYB |
3:45pm - 4:15pm | Psychosocial Implications for Individuals with SCD | Paula J. Tanabe, PhD, MSN, FAAN |
4:15pm - 4:30pm |
Evaluation and Closing Remarks |
Kenneth Ataga, MD |
Keynote speakers:
Jane S. Hankins, MD, MS
Global Pediatric Medicine
St. Jude Children's Research Hospital
Memphis, Tennessee
Wally R. Smith, MD
Florence Neal Cooper Smith Professor of Sickle Cell Disease
Vice Chair for Research
Virginia Commonwealth University
Richmond, Virginia
Paula J. Tanabe, PhD MSN
Laurel Chadwick Distinguished Professor of Nursing
Professor in the School of Nursing
Vice Dean, Research and Regulatory Affairs
Assistant Professor in Surgery
Professor of Medicine
Affiliate Faculty Member, Duke-Margolis Center for Health Policy
Russell Ware, MD, PhD
Director, Division of Hematology
Institute Co-Executive Director, Cancer and Blood Diseases Institute Director, Global Health Center
Marjory J. Johnson Chair of Hematology Translational Research
Professor, University of Cincinnati, Department of Pediatrics
Cincinnati, Ohio
A conflict of Interest occurs when an individual has an opportunity to affect educational content about health-care products or services of a commercial interest with which she/he has a financial relationship. The planners and presenters of this NCPD/CME activity have disclosed no relevant financial relationships with any commercial interests pertaining to this activity.
Commercial Support: No
Noncommercial Sponsor Support: No
Off-label Product Use: This NCPD activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).
Sara Day, PhD, RN, FAAN
Jane S Hankins, MD, MS
Karen Nellis, BSN, RN, AE-C
Jane S Hankins, MD, MS
Paula Tanabe, PhD
5.5 CME/CEU credits provided
In order to receive full contact credit(s) for this NCPD/CME activity, you must:
• Be in attendance for at least 80% of the program, and
• Complete and submit the Evaluation at the conclusion of the program.
| AMA Credit Designation: The University of Tennessee College of Medicine (UTCOM) designates this live activity for a maximum of 5.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Education for Non-Physicians: The UTCOM will issue Certificates of Participation to non-physicians for participating in this activity and designates it for CEUs using the national standard that 1 hour of educational instruction is awarded .1 CEU. Accreditation: The UTCOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of TN Health Science Center College of Nursing, Memphis, is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
|
Available Credit
- 5.50 AMA PRA Category 1 Credit™
- 5.50 ANCC
- 5.50 Attendance